Forte Biosciences FBRX
FBRX
$76.99 +0.00 (+0.00%)
At close: Aug 28, 2026 · 4:00 PM EDT

Forte Biosciences (FBRX) Accounts Payables (2016 - 2026)

Updated

Forte Biosciences (FBRX) reported Accounts Payables of $14.01 million for Q2 2026, up 164.3% from $5.3 million a year earlier and up 7.1% from the prior quarter.

Analysis

Forte Biosciences (FBRX) Accounts Payables (2016 - 2026) Analysis & Trends

At the end of FY2025, Forte Biosciences posted Accounts Payables of $9.99 million, up 104.7% from FY2024.

  • Accounts Payables has increased for four consecutive years, with a five-year compound annual growth rate of 51.8% (FY2020 to FY2025).
  • By year, Accounts Payables came in at $4.88 million in FY2024 (+242.6%), $1.42 million in FY2023 (+23.5%), $1.15 million in FY2022 (+21.9%) and $946,000 in FY2021 (-23.7%).
  • The Q2 2026 figure ranks as the highest quarterly Accounts Payables in data going back to Q4 2016.
  • Year over year, Accounts Payables has now increased in each of the last seven quarters, with growth averaging 109.2% over the last eight quarters.
  • The high point for year-over-year Accounts Payables in five years was Q3 2023 (growth of 349.5%); the low point was Q1 2022 (a decline of 52.2%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $13.08 million (Q1 2026), $9.99 million (Q4 2025) and $5.49 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 9.22 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 33.30 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -22.89 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 674.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 429.50 Mn
10 Forte Biosciences 1.58 Bn 1.38 Bn - 14.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.01 Mn
Mar 31, 2026 13.08 Mn
Dec 31, 2025 9.99 Mn
Sep 30, 2025 5.49 Mn
Jun 30, 2025 5.30 Mn
Mar 31, 2025 5.02 Mn
Dec 31, 2024 4.88 Mn
Sep 30, 2024 5.16 Mn
Jun 30, 2024 5.28 Mn
Mar 31, 2024 1.69 Mn
Dec 31, 2023 1.42 Mn
Sep 30, 2023 5.35 Mn
Jun 30, 2023 3.01 Mn
Mar 31, 2023 1.34 Mn
Dec 31, 2022 1.15 Mn
Sep 30, 2022 1.19 Mn
Jun 30, 2022 698,000.00
Mar 31, 2022 576,000.00
Dec 31, 2021 946,000.00
Sep 30, 2021 2.33 Mn
API Access

Forte Biosciences Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=FBRX&period=max&api_key=YOUR_API_KEY